SEER Q3 2024 Earnings — Seer, Inc. Revenue & Financial Results | Market Cap Arena

SEERSeer, Inc.

$101M

Q3 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$4M-5.3% YoY

Gross Profit

$2M46.9% margin

Operating Income

-$24M-617.1% margin

Net Income

-$21M-541.0% margin

EPS (Diluted)

$-0.35

QoQ Revenue Growth

+28.3%

Cash Flow

Operating Cash Flow

-$14M

Free Cash Flow

-$16M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$383M

Total Liabilities

$39M

Stockholders' Equity

$345M

Cash & Equivalents

$38M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$4M	-5.3%
Gross Profit	$2M	$658,000	+180.9%
Operating Income	-$24M	-$26M	+5.9%
Net Income	-$21M	-$21M	-1.1%